MAIA Biotechnology Announces Closing of $4 Million Registered Direct Offering | News

Retrieved on: 2023-11-17 21:28:44

Tags for this article:

Communication

Forward-looking statement

Auditor's report

MAIA Biotechnology Inc.

Click the tags to see associated articles and topics

MAIA Biotechnology Announces Closing of $4 Million Registered Direct Offering | News. View article details on hiswai:

Excerpt

MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA” or the “Company”), a clinical-stage biopharmaceutical company developing telomere-targeting ...

Article found on: www.bakersfield.com

View Original Article